SeaCrest Wealth Management, LLC - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 39 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is 34.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
SeaCrest Wealth Management, LLC ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2019$4,000
+33.3%
5000.0%0.00%0.0%
Q4 2018$3,000
-57.1%
5000.0%0.00%0.0%
Q3 2018$7,000
+16.7%
5000.0%0.00%0.0%
Q2 2018$6,0005000.00%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q3 2018
NameSharesValueWeighting ↓
BVF INC/IL 1,347,755$574,8180.02%
Virtu Financial LLC 31,633$130.00%
Western Wealth Management, LLC 29,537$12,5970.00%
Belpointe Asset Management LLC 14,050$5,9920.00%
TSFG, LLC 3,000$10.00%
ZRC WEALTH MANAGEMENT, LLC 100$430.00%
Allworth Financial LP 250$1070.00%
JANE STREET GROUP, LLC 13,189$5,6250.00%
RAYMOND JAMES & ASSOCIATES 138,040$58,8740.00%
BOURGEON CAPITAL MANAGEMENT LLC 500$2140.00%
View complete list of GALMED PHARMACEUTICALS LTD shareholders